RGNX - Regenxbio Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Biological Products, (No Diagnostic Substances) - RGNX (1590877)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
71 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2019-12-09
RGNXSimpson CurranSVP, Product Development, CTOS - Sale$43.74-15,55223,948-39%-$680,248
D
2019-09-19
RGNXMills Kenneth T.Pres, CEOS - Sale+OE$39.75-10,000241,000-4%-$397,497
D
2019-09-12
RGNXChristmas Patrick J.SVP, GCS - Sale+OE$42.00-5,4862,572-68%-$230,412
D
2019-08-19
RGNXMills Kenneth T.Pres, CEOS - Sale+OE$37.55-15,000246,000-6%-$563,243
D
2019-07-19
RGNXMills Kenneth T.Pres, CEOS - Sale+OE$49.49-15,000246,000-6%-$742,311
DM
2019-07-18
RGNXChristmas Patrick J.SVP, GCS - Sale+OE$50.03-5,0003,058-62%-$250,147
D
2019-06-19
RGNXMills Kenneth T.Pres, CEOS - Sale+OE$52.54-15,000246,000-6%-$788,088
D
2019-06-18
RGNXChristmas Patrick J.SVP, GCS - Sale+OE$52.99-5,0003,006-62%-$264,965
D
2019-05-28
RGNXSimpson CurranSVP, Product Development, CTOS - Sale+OE$50.00-18,00039,500-31%-$900,000
D
2019-05-20
RGNXMills Kenneth T.Pres, CEOS - Sale+OE$42.99-15,000246,000-6%-$644,866
D
2019-04-22
RGNXMills Kenneth T.Pres, CEOS - Sale+OE$50.44-15,000246,000-6%-$756,566
D
2019-04-18
RGNXChristmas Patrick J.SVP, GCS - Sale+OE$53.23-5,0003,006-62%-$266,161
D
2019-04-15
RGNXDanos OlivierChief Scientific OfficerS - Sale+OE$52.66-2,0006,500-24%-$105,320
2019-03-21
RGNXVasista VittalCFOS - Sale$60.75-10,000229,215-4%-$607,539
D
2019-03-19
RGNXMills Kenneth T.Pres, CEOS - Sale+OE$58.53-15,000246,000-6%-$877,989
2019-03-05
RGNXVasista VittalCFOS - Sale$60.01-3,068239,215-1%-$184,111
D
2019-02-25
RGNXSimpson CurranSVP, Product Development, CTOS - Sale+OE$54.05-5,30039,500-12%-$286,465
D
2019-02-15
RGNXMills Kenneth T.Pres, CEOS - Sale+OE$47.29-15,000246,000-6%-$709,284
D
2019-02-05
RGNXSimpson CurranSVP, Product Development, CTOS - Sale+OE$50.08-43,83239,500-53%-$2,195,107
2019-01-15
RGNXMills Kenneth T.Pres, CEOS - Sale$43.85-15,000201,000-7%-$657,698
D
2018-12-18
RGNXChristmas Patrick J.SVP, GCS - Sale+OE$47.54-5,0002,669-65%-$237,698
2018-12-17
RGNXVasista VittalCFOS - Sale$46.35-7,500122,283-6%-$347,650
2018-12-17
RGNXMills Kenneth T.Pres, CEOS - Sale$46.73-15,000216,000-6%-$700,927
D
2018-12-03
RGNXYoo StephenChief Medical OfficerS - Sale+OE$60.13-20,4140-100%-$1,227,412
2018-12-03
RGNXMills Kenneth T.Pres, CEOS - Sale$60.40-20,000231,000-8%-$1,208,087
D
2018-11-29
RGNXBeshar Luke MDirS - Sale+OE$65.00-12,7840-100%-$830,960
DM
2018-11-26
RGNXBeshar Luke MDirS - Sale+OE$65.03-20,5070-100%-$1,333,519
2018-11-26
RGNXMills Kenneth T.Pres, CEOS - Sale$64.17-20,000251,000-7%-$1,283,355
DM
2018-11-19
RGNXBeshar Luke MDirS - Sale+OE$60.44-33,2920-100%-$2,012,209
D
2018-11-16
RGNXSimpson CurranSVP, Technical OperationsS - Sale+OE$63.76-32,88239,500-45%-$2,096,419
2018-11-15
RGNXVasista VittalCFOS - Sale$60.29-7,500129,783-5%-$452,206
2018-11-07
RGNXChristmas Patrick J.SVP, GCS - Sale$72.06-15,0002,669-85%-$1,080,900
D
2018-11-05
RGNXYoo StephenChief Medical OfficerS - Sale+OE$68.28-20,4140-100%-$1,393,933
2018-11-05
RGNXMills Kenneth T.Pres, CEOS - Sale$68.25-20,000306,000-6%-$1,364,902
DM
2018-11-01
RGNXVasista VittalCFOS - Sale+OE$70.20-73,418137,283-35%-$5,154,020
D
2018-10-29
RGNXYoo StephenChief Medical OfficerS - Sale+OE$62.37-20,4140-100%-$1,273,212
D
2018-10-18
RGNXChristmas Patrick J.SVP, GCS - Sale+OE$61.78-5,00017,669-22%-$308,890
D
2018-10-16
RGNXSimpson CurranSVP, Technical OperationsS - Sale+OE$60.85-62,30939,500-61%-$3,791,503
DM
2018-10-15
RGNXYoo StephenChief Medical OfficerS - Sale+OE$60.28-20,4140-100%-$1,230,541
2018-10-15
RGNXVasista VittalCFOS - Sale$59.37-7,500137,283-5%-$445,275
2018-10-15
RGNXMills Kenneth T.Pres, CEOS - Sale$59.35-7,510326,000-2%-$445,745
D
2018-10-08
RGNXDanos OlivierChief Scientific OfficerS - Sale+OE$63.80-20,0000-100%-$1,275,914
D
2018-09-17
RGNXVasista VittalCFOS - Sale+OE$74.86-7,500144,783-5%-$561,472
2018-09-17
RGNXMills Kenneth T.Pres, CEOS - Sale$74.91-7,510333,510-2%-$562,564
D
2018-08-27
RGNXMills Kenneth T.Pres, CEOS - Sale+OE$66.46-7,510341,020-2%-$499,118
D
2018-08-20
RGNXChristmas Patrick J.SVP, GCS - Sale+OE$65.96-5,00017,669-22%-$329,806
2018-08-15
RGNXVasista VittalCFOS - Sale$65.43-7,500122,283-6%-$490,710
2018-07-16
RGNXVasista VittalCFOS - Sale$75.54-7,500129,783-5%-$566,522
2018-06-20
RGNXMills Kenneth T.Pres, CEOS - Sale$66.20-5,000203,530-2%-$331,018
D
2018-06-18
RGNXChristmas Patrick J.SVP, GCS - Sale+OE$56.78-5,00017,669-22%-$283,886
2018-06-15
RGNXVasista VittalCFOS - Sale$56.61-7,500137,283-5%-$424,540
DM
2018-06-01
RGNXHayden Donald J JrDirS - Sale+OE$55.01-15,0000-100%-$825,149
2018-05-21
RGNXMills Kenneth T.Pres, CEOS - Sale$47.05-10,000208,530-5%-$470,540
2018-05-15
RGNXVasista VittalCFOS - Sale$50.10-7,500144,783-5%-$375,721
DM
2018-05-14
RGNXHayden Donald J JrDirS - Sale+OE$50.05-15,0000-100%-$750,797
D
2018-05-09
RGNXChristmas Patrick J.SVP, GCS - Sale+OE$43.33-15,00016,141-48%-$650,000
D
2018-05-09
RGNXHayden Donald J JrDirS - Sale+OE$45.00-15,0000-100%-$675,000
2018-04-20
RGNXMills Kenneth T.Pres, CEOS - Sale$39.52-10,000218,530-4%-$395,205
2018-04-16
RGNXVasista VittalCFOS - Sale$37.56-5,000152,283-3%-$187,797
D
2018-04-11
RGNXChristmas Patrick J.SVP, GCS - Sale+OE$39.00-10,0001,141-90%-$390,000
D
2018-04-09
RGNXChristmas Patrick J.SVP, GCS - Sale+OE$34.00-10,0001,141-90%-$340,000
2018-03-26
RGNXVasista VittalCFOS - Sale$30.00-5,000157,283-3%-$150,000
2018-03-20
RGNXMills Kenneth T.Pres, CEOS - Sale$29.55-10,000228,530-4%-$295,500
D
2018-03-13
RGNXSimpson CurranSVP, Technical OperationsS - Sale+OE$33.00-25,00039,500-39%-$825,000
2018-02-28
RGNXVasista VittalCFOS - Sale$30.00-5,000102,283-5%-$150,000
2018-02-20
RGNXMills Kenneth T.Pres, CEOS - Sale$26.56-10,000238,530-4%-$265,600
2018-01-22
RGNXMills Kenneth T.Pres, CEOS - Sale$27.33-10,000248,530-4%-$273,300
2018-01-16
RGNXVasista VittalCFOS - Sale$30.16-5,000107,283-4%-$150,800
D
2017-12-22
RGNXSimpson CurranSVP, Technical OperationsS - Sale+OE$33.03-30,00039,500-43%-$990,900
2017-12-20
RGNXMills Kenneth T.Pres, CEOS - Sale$31.75-10,000108,530-8%-$317,500
M
2017-12-18
RGNXVasista VittalCFOS - Sale$30.00-5,00082,283-6%-$150,000
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top